Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-17-017470

Options or other derivatives

  • Chief Executive Officer acquired 377,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cohen Yuval · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-03-01 Grant or award : show line 1 in the form Stock Option(right to buy) +377,500 $9.05 2027-03-01 377,500 377,500 D
Loading xslF345X03/doc4.xml…